Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiadai Xu

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Oncotargets and Therapy|July 9, 2016
The clinical significance of γ-catenin in acute myeloid leukemiaJiadai Xu, Wei Wu, Wenyi Shen, et al.
Genes & Diseases|November 13, 2024
IGF2BP1 promotes multiple myeloma with chromosome 1q gain via increasing CDC5L expression in an m<sup>6</sup>A-dependent mannerJiadai Xu, Yawen Wang, Liang Ren, et al.
Cancer Medicine|November 15, 2023
The loss of neoantigens is an important reason for immune escape in multiple myeloma patients with high intratumor heterogeneityYue Wang, Jiadai Xu, Tianwei Lan, et al.
BMJ Open|September 16, 2020
Screening for monoclonal B-lymphocyte expansion in a hospital-based Chinese population with lymphocytosis: an observational cohort studyJiadai Xu, Jing Li, Zheng Wei, et al.
Cancer Medicine|August 12, 2020
ZHX2 mediates proteasome inhibitor resistance via regulating nuclear translocation of NF-κB in multiple myelomaJifeng Jiang, Yifeng Sun, Jiadai Xu, et al.
Annals of Hematology|November 13, 2023
Zanubrutinib-lenalidomide-rituximab (ZR<sup>2</sup>) in unfit diffuse large B-cell lymphoma: efficient and tolerantYawen Wang, Jiadai Xu, Panpan Li, et al.
Frontiers in Oncology|October 5, 2020
High Expression of Succinate Dehydrogenase Subunit A Which Is Regulated by Histone Acetylation, Acts as a Good Prognostic Factor of Multiple Myeloma PatientsYifeng Sun, Zhao Xu, Jifeng Jiang, et al.
Biomed Research International|January 29, 2019
A Novel Scoring System Based on the Level of HDL-C for Predicting the Prognosis of t-DLBCL Patients: A Single Retrospective StudyJiadai Xu, Zheng Wei, Yian Zhang, et al.
Oncotargets and Therapy|August 9, 2020
Suppression of CXCL-1 Could Restore Necroptotic Pathway in Chronic Lymphocytic LeukemiaZhao Xu, Yifeng Sun, Zheng Wei, et al.
American Journal of Cancer Research|April 6, 2019
Chidamide, a novel histone deacetylase inhibitor, inhibits multiple myeloma cells proliferation through succinate dehydrogenase subunit AYifeng Sun, Jing Li, Zhao Xu, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Oncotargets and Therapy|July 9, 2016
The clinical significance of γ-catenin in acute myeloid leukemiaJiadai Xu, Wei Wu, Wenyi Shen, et al.
Genes & Diseases|November 13, 2024
IGF2BP1 promotes multiple myeloma with chromosome 1q gain via increasing CDC5L expression in an m<sup>6</sup>A-dependent mannerJiadai Xu, Yawen Wang, Liang Ren, et al.
Cancer Medicine|November 15, 2023
The loss of neoantigens is an important reason for immune escape in multiple myeloma patients with high intratumor heterogeneityYue Wang, Jiadai Xu, Tianwei Lan, et al.
BMJ Open|September 16, 2020
Screening for monoclonal B-lymphocyte expansion in a hospital-based Chinese population with lymphocytosis: an observational cohort studyJiadai Xu, Jing Li, Zheng Wei, et al.
Cancer Medicine|August 12, 2020
ZHX2 mediates proteasome inhibitor resistance via regulating nuclear translocation of NF-κB in multiple myelomaJifeng Jiang, Yifeng Sun, Jiadai Xu, et al.
Annals of Hematology|November 13, 2023
Zanubrutinib-lenalidomide-rituximab (ZR<sup>2</sup>) in unfit diffuse large B-cell lymphoma: efficient and tolerantYawen Wang, Jiadai Xu, Panpan Li, et al.
Frontiers in Oncology|October 5, 2020
High Expression of Succinate Dehydrogenase Subunit A Which Is Regulated by Histone Acetylation, Acts as a Good Prognostic Factor of Multiple Myeloma PatientsYifeng Sun, Zhao Xu, Jifeng Jiang, et al.
Biomed Research International|January 29, 2019
A Novel Scoring System Based on the Level of HDL-C for Predicting the Prognosis of t-DLBCL Patients: A Single Retrospective StudyJiadai Xu, Zheng Wei, Yian Zhang, et al.
Oncotargets and Therapy|August 9, 2020
Suppression of CXCL-1 Could Restore Necroptotic Pathway in Chronic Lymphocytic LeukemiaZhao Xu, Yifeng Sun, Zheng Wei, et al.
American Journal of Cancer Research|April 6, 2019
Chidamide, a novel histone deacetylase inhibitor, inhibits multiple myeloma cells proliferation through succinate dehydrogenase subunit AYifeng Sun, Jing Li, Zhao Xu, et al.
Pageof 4